Fig. 3From: Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year resultsTime-dependent changes in a ulcer area (p < 0.0001), b ABI (p = 0.806), c TBI (p < 0.0001), d transcutaneous oxygen pressure (TcPO2; p < 0.0001), and e pain score (p < 0.0001). ABMMNC autologous bone marrow-derived mononuclear cellsBack to article page